Time filter

Source Type

International Society For Cellular Therapy | Date: 2015-11-11

Printed materials, namely, journals featuring information, news and opinion about cell therapy.

Eaker S.,International Society for Cellular Therapy | Eaker S.,General Electric | Armant M.,International Society for Cellular Therapy | Armant M.,Harvard University | And 17 more authors.
Stem Cells Translational Medicine | Year: 2013

Cell therapy is poised to play an enormous role in regenerative medicine. However, little guidance is being made available to academic and industrial entities in the start-up phase. In this technical review, members of the International Society for Cell Therapy provide guidance in developing commercializable autologous and patient-specific manufacturing strategies from the perspective of process development. Special emphasis is placed on providing guidance to small academic or biotech researchers as to what simple questions can be addressed or answered at the bench in order to make their cell therapy products more feasible for commercial-scale production. We discuss the processes that are required for scale-out at the manufacturing level, and how many questions can be addressed at the bench level. The goal of this review is to provide guidance in the form of topics that can be addressed early in the process of development to better the chances of the product being successful for future commercialization. © AlphaMed Press 2013.

Maziarz R.T.,Oregon Health And Science University | Arthurs J.,International Society for Cellular Therapy | Horwitz E.,Childrens Hospital of Philadelphia
Regenerative Medicine | Year: 2011

The International Society for Cellular Therapy is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. Established in 1992, its membership and leadership comprises world-class scientists, clinicians, technologists, biotech/pharma and regulatory professionals from 40 countries focused on preclinical and translational aspects of developing cell therapy products. The International Society for Cellular Therapy has evolved in alignment with the maturation of the field of cell therapy and regenerative medicine to create forums for discussion of shared concerns for commercialization of cell therapies and of development of consensus standards, recognizing that true commercialization depends upon the translational scientific community, the regional regulatory and policy institutions, and the technology support and capital investment from industry. It exists to facilitate the international work of many, to spawn new initiatives, and to synergize with other stakeholders to create the best outcome for the many patients across the world depending on the answers and improved health that cellular therapeutics will provide them. © 2011 Future Medicine Ltd.

Discover hidden collaborations